The shares of $CVS (+0,57%) , $UNH (+1,64%) and other US companies in the healthcare sector drifted further downwards today.
The reason for this is the increasing speculation surrounding the plans of the orange-colored future head of state.
He plans to eliminate "the middleman". The middleman are dealers who help determine the final prices of drugs, but do not necessarily offer an add-on.
If the new administration really pushes this through, it will probably only be the beginning of a correction in the U.S. healthcare system.
What is your opinion on this?
